Yuhan-Kimberly Launches Exclusive Sales of 'Breswit Allergy Blocker' Medical Device

- Expectation for Allergy Care Solutions and Capability Enhancement
- Focus on Online and Own Mall Sales for Purchase Convenience and Channel Diversification

Yuhan-Kimberly (CEO Jin Jae-seung) announced that it has formed a strategic partnership with Korea Menarini (CEO Park Hye-young) to exclusively sell the medical device "Breswit Allergy Blocker" (hereinafter "Breswit") in Korea, which proactively blocks allergy-causing substances.

Yuhan-Kimberly has already been supplying products such as Allergy Comfort Lotion Tissues, Nose Comfort Tissues, and Runny Nose/Eye Area Wet Wipes, designed to minimize skin irritation when wiping nasal discharge or tears caused by allergies. The exclusive sale of Breswit is expected to significantly contribute to building an integrated allergy care solution and expanding related business capabilities.

Breswit, a spray-type medical device, focuses on the proactive prevention of allergens by forming a protective barrier on the nasal mucosa. When sprayed inside the nose, the fine powder mainly composed of hydroxypropyl methylcellulose (HPMC) forms a protective film that helps block allergy-causing substances such as pollen, house dust, pet hair, and mold.

According to data from the Health Insurance Review & Assessment Service, allergic rhinitis patients in Korea exceeded 6 million last year alone, making it a common condition that causes significant discomfort in daily life due to symptoms such as sneezing, runny nose, and itching. The World Health Organization (WHO) also emphasizes in its international guidelines on allergic rhinitis and asthma that the first step in managing allergic rhinitis is to avoid allergens. Therefore, it is important to proactively prevent the root causes of allergies whenever possible.

Breswit is an imported product by Korea Menarini and has secured various clinical data. Its fine powder formulation does not drip when sprayed, providing convenience, and the effect typically lasts 4 to 6 hours per spray. Additionally, it contains no medicinal ingredients, so there is no risk of drug resistance or drowsiness, and clinical data for infants over 18 months and pregnant women are also available.

A Yuhan-Kimberly representative stated, "In line with consumers' growing interest in allergy care, we have been focusing on developing and expanding related product lines centered on the Kleenex brand," adding, "With the sales partnership for Breswit, we can extend our allergy care portfolio to the prevention area, and we expect related business to gain further momentum."

Breswit will be sold through online channels and Yuhan-Kimberly’s own mall to enhance consumer convenience and diversify channels. A launch commemorative trial event will also be held at the Naver Brand Store and the company’s mall, Oneul Plus, where sales have begun.